AAPL343.57+1.57 (+0.46%) ▲|ABBV285.36+1.96 (+0.69%) ▲|ABT104.89+0.21 (+0.20%) ▲|ACN229.63+4.71 (+2.09%) ▲|ADBE245.20-6.47 (-2.57%) ▼|AMAT409.29-20.72 (-4.82%) ▼|AMD528.75-33.48 (-5.95%) ▼|AMGN432.49-1.54 (-0.35%) ▼|AMT185.29+3.93 (+2.16%) ▲|AMZN250.00-4.76 (-1.87%) ▼|AVGO328.75-15.58 (-4.52%) ▼|AXP313.60-0.27 (-0.09%) ▼|BA190.04+1.31 (+0.69%) ▲|BAC51.23-0.48 (-0.92%) ▼|BKNG163.45-2.35 (-1.42%) ▼|BLK1,133.87+13.09 (+1.17%) ▲|BMY59.84-0.74 (-1.21%) ▼|BNY143.25+1.16 (+0.82%) ▲|BRK-B532.02+6.34 (+1.21%) ▲|C124.23+1.02 (+0.83%) ▲|CAT730.79-4.85 (-0.66%) ▼|CL94.08+1.41 (+1.52%) ▲|CMCSA21.90+0.13 (+0.60%) ▲|COF201.74+2.88 (+1.45%) ▲|COP146.51+4.78 (+3.37%) ▲|COST989.11+11.10 (+1.14%) ▲|CRM240.68-6.06 (-2.46%) ▼|CSCO107.39-2.46 (-2.24%) ▼|CVS92.37-0.21 (-0.23%) ▼|CVX224.97+5.65 (+2.58%) ▲|DE641.85-8.82 (-1.36%) ▼|DHR229.03-2.47 (-1.07%) ▼|DIS110.57-0.11 (-0.10%) ▼|DUK121.47+2.59 (+2.18%) ▲|EMR161.45-0.70 (-0.43%) ▼|FDX293.53-2.01 (-0.68%) ▼|GD344.15+7.12 (+2.11%) ▲|GE313.94+1.94 (+0.62%) ▲|GEV921.02-5.42 (-0.59%) ▼|GILD156.19-1.18 (-0.75%) ▼|GM83.96+0.30 (+0.36%) ▲|GOOG336.91-8.00 (-2.32%) ▼|GOOGL340.59-8.63 (-2.47%) ▼|GS880.60-10.69 (-1.20%) ▼|HD309.63+1.39 (+0.45%) ▲|HON211.41+0.91 (+0.43%) ▲|IBM232.14-1.98 (-0.85%) ▼|INTC89.85-5.52 (-5.79%) ▼|INTU325.15-5.02 (-1.52%) ▼|ISRG426.70-1.16 (-0.27%) ▼|JNJ255.60+2.32 (+0.92%) ▲|JPM339.72+4.19 (+1.25%) ▲|KO93.86+1.86 (+2.02%) ▲|LIN498.43+5.21 (+1.06%) ▲|LLY1,257.26+5.65 (+0.45%) ▲|LMT551.73+19.09 (+3.58%) ▲|LOW197.35+1.63 (+0.83%) ▲|LRCX263.94-13.52 (-4.87%) ▼|MA617.24+0.92 (+0.15%) ▲|MCD242.94+0.44 (+0.18%) ▲|MDLZ63.91+0.88 (+1.40%) ▲|MDT94.76-0.69 (-0.72%) ▼|META709.33-27.40 (-3.72%) ▼|MMM164.72-0.61 (-0.37%) ▼|MO75.10+1.26 (+1.71%) ▲|MRK145.93+0.74 (+0.51%) ▲|MS180.53-1.57 (-0.86%) ▼|MSFT529.05-10.39 (-1.93%) ▼|MU878.84-52.40 (-5.63%) ▼|NEE79.79+0.83 (+1.05%) ▲|NFLX70.53-2.08 (-2.86%) ▼|NKE37.13-0.02 (-0.04%) ▼|NOW141.95-6.62 (-4.46%) ▼|NVDA214.13-3.10 (-1.43%) ▼|ORCL128.22-6.25 (-4.65%) ▼|PEP131.49+3.11 (+2.42%) ▲|PFE29.57+0.13 (+0.44%) ▲|PG159.33+2.25 (+1.43%) ▲|PLTR186.03-14.47 (-7.22%) ▼|PM204.93+5.03 (+2.52%) ▲|QCOM172.11-6.29 (-3.53%) ▼|RTX193.92+6.97 (+3.73%) ▲|SBUX97.52+0.64 (+0.66%) ▲|SCHW91.96-2.20 (-2.34%) ▼|SO91.18+2.00 (+2.24%) ▲|SPG205.44+2.05 (+1.01%) ▲|T23.57+0.07 (+0.28%) ▲|TMO690.37-6.12 (-0.88%) ▼|TMUS159.10+2.07 (+1.32%) ▲|TSLA354.72-7.72 (-2.13%) ▼|TXN278.65-0.47 (-0.17%) ▼|UBER70.00-1.28 (-1.79%) ▼|UNH402.21-4.46 (-1.10%) ▼|UNP287.50-1.21 (-0.42%) ▼|UPS96.89-0.95 (-0.97%) ▼|USB58.43+1.04 (+1.80%) ▲|V401.07+1.32 (+0.33%) ▲|VZ44.84+0.44 (+0.99%) ▲|WFC83.59+0.84 (+1.02%) ▲|WMT118.73+0.86 (+0.73%) ▲|XOM178.13+3.45 (+1.98%) ▲|AAPL343.57+1.57 (+0.46%) ▲|ABBV285.36+1.96 (+0.69%) ▲|ABT104.89+0.21 (+0.20%) ▲|ACN229.63+4.71 (+2.09%) ▲|ADBE245.20-6.47 (-2.57%) ▼|AMAT409.29-20.72 (-4.82%) ▼|AMD528.75-33.48 (-5.95%) ▼|AMGN432.49-1.54 (-0.35%) ▼|AMT185.29+3.93 (+2.16%) ▲|AMZN250.00-4.76 (-1.87%) ▼|AVGO328.75-15.58 (-4.52%) ▼|AXP313.60-0.27 (-0.09%) ▼|BA190.04+1.31 (+0.69%) ▲|BAC51.23-0.48 (-0.92%) ▼|BKNG163.45-2.35 (-1.42%) ▼|BLK1,133.87+13.09 (+1.17%) ▲|BMY59.84-0.74 (-1.21%) ▼|BNY143.25+1.16 (+0.82%) ▲|BRK-B532.02+6.34 (+1.21%) ▲|C124.23+1.02 (+0.83%) ▲|CAT730.79-4.85 (-0.66%) ▼|CL94.08+1.41 (+1.52%) ▲|CMCSA21.90+0.13 (+0.60%) ▲|COF201.74+2.88 (+1.45%) ▲|COP146.51+4.78 (+3.37%) ▲|COST989.11+11.10 (+1.14%) ▲|CRM240.68-6.06 (-2.46%) ▼|CSCO107.39-2.46 (-2.24%) ▼|CVS92.37-0.21 (-0.23%) ▼|CVX224.97+5.65 (+2.58%) ▲|DE641.85-8.82 (-1.36%) ▼|DHR229.03-2.47 (-1.07%) ▼|DIS110.57-0.11 (-0.10%) ▼|DUK121.47+2.59 (+2.18%) ▲|EMR161.45-0.70 (-0.43%) ▼|FDX293.53-2.01 (-0.68%) ▼|GD344.15+7.12 (+2.11%) ▲|GE313.94+1.94 (+0.62%) ▲|GEV921.02-5.42 (-0.59%) ▼|GILD156.19-1.18 (-0.75%) ▼|GM83.96+0.30 (+0.36%) ▲|GOOG336.91-8.00 (-2.32%) ▼|GOOGL340.59-8.63 (-2.47%) ▼|GS880.60-10.69 (-1.20%) ▼|HD309.63+1.39 (+0.45%) ▲|HON211.41+0.91 (+0.43%) ▲|IBM232.14-1.98 (-0.85%) ▼|INTC89.85-5.52 (-5.79%) ▼|INTU325.15-5.02 (-1.52%) ▼|ISRG426.70-1.16 (-0.27%) ▼|JNJ255.60+2.32 (+0.92%) ▲|JPM339.72+4.19 (+1.25%) ▲|KO93.86+1.86 (+2.02%) ▲|LIN498.43+5.21 (+1.06%) ▲|LLY1,257.26+5.65 (+0.45%) ▲|LMT551.73+19.09 (+3.58%) ▲|LOW197.35+1.63 (+0.83%) ▲|LRCX263.94-13.52 (-4.87%) ▼|MA617.24+0.92 (+0.15%) ▲|MCD242.94+0.44 (+0.18%) ▲|MDLZ63.91+0.88 (+1.40%) ▲|MDT94.76-0.69 (-0.72%) ▼|META709.33-27.40 (-3.72%) ▼|MMM164.72-0.61 (-0.37%) ▼|MO75.10+1.26 (+1.71%) ▲|MRK145.93+0.74 (+0.51%) ▲|MS180.53-1.57 (-0.86%) ▼|MSFT529.05-10.39 (-1.93%) ▼|MU878.84-52.40 (-5.63%) ▼|NEE79.79+0.83 (+1.05%) ▲|NFLX70.53-2.08 (-2.86%) ▼|NKE37.13-0.02 (-0.04%) ▼|NOW141.95-6.62 (-4.46%) ▼|NVDA214.13-3.10 (-1.43%) ▼|ORCL128.22-6.25 (-4.65%) ▼|PEP131.49+3.11 (+2.42%) ▲|PFE29.57+0.13 (+0.44%) ▲|PG159.33+2.25 (+1.43%) ▲|PLTR186.03-14.47 (-7.22%) ▼|PM204.93+5.03 (+2.52%) ▲|QCOM172.11-6.29 (-3.53%) ▼|RTX193.92+6.97 (+3.73%) ▲|SBUX97.52+0.64 (+0.66%) ▲|SCHW91.96-2.20 (-2.34%) ▼|SO91.18+2.00 (+2.24%) ▲|SPG205.44+2.05 (+1.01%) ▲|T23.57+0.07 (+0.28%) ▲|TMO690.37-6.12 (-0.88%) ▼|TMUS159.10+2.07 (+1.32%) ▲|TSLA354.72-7.72 (-2.13%) ▼|TXN278.65-0.47 (-0.17%) ▼|UBER70.00-1.28 (-1.79%) ▼|UNH402.21-4.46 (-1.10%) ▼|UNP287.50-1.21 (-0.42%) ▼|UPS96.89-0.95 (-0.97%) ▼|USB58.43+1.04 (+1.80%) ▲|V401.07+1.32 (+0.33%) ▲|VZ44.84+0.44 (+0.99%) ▲|WFC83.59+0.84 (+1.02%) ▲|WMT118.73+0.86 (+0.73%) ▲|XOM178.13+3.45 (+1.98%) ▲|
21.2 C
New York
Friday, October 16, 2026

Tag: injection

Fosun International Wins Five Awards at The Asset Corporate Sustainability Leadership Awards 2026, Upgraded to Platinum

HONG KONG, Oct. 13, 2026 /PRNewswire/ -- Fosun International Limited ("Fosun International" or the "Company") (HKEX stock code: 00656) today announced that it has...

Fosun International Wins Five Awards at The Asset Corporate Sustainability Leadership Awards 2026, Upgraded to Platinum

HONG KONG, Oct. 13, 2026 /PRNewswire/ -- Fosun International Limited ("Fosun International" or the "Company") (HKEX stock code: 00656) today announced that it has...

Interim Real-World Results Show At-Home Subcutaneous Furosemide Can Effectively Treat Worsening Heart Failure in Patients at Imminent Risk for Hospital Admission

Gator SCALES-WHF, an investigator-sponsored study at the University of Florida, shows effective decongestion of patients at imminent risk for hospital admission with minimal user,...

FAKUMA 2026: ENVALIOR UNVEILS HIGH-PERFORMANCE MATERIAL SOLUTIONS FOR NEXT GENERATION DATA CENTERS

At Fakuma 2026, Envalior showcases its latest material solutions for reliable data center power distribution, connectivity, and cooling components.Envalior materials and expertise help to...

FAKUMA 2026: ENVALIOR UNVEILS HIGH-PERFORMANCE MATERIAL SOLUTIONS FOR NEXT GENERATION DATA CENTERS

At Fakuma 2026, Envalior showcases its latest material solutions for reliable data center power distribution, connectivity, and cooling components.Envalior materials and expertise help to...

FAKUMA 2026: ENVALIOR UNVEILS HIGH-PERFORMANCE MATERIAL SOLUTIONS FOR NEXT GENERATION DATA CENTERS

At Fakuma 2026, Envalior showcases its latest material solutions for reliable data center power distribution, connectivity, and cooling components.Envalior materials and expertise help to...

FAKUMA 2026: ENVALIOR UNVEILS HIGH-PERFORMANCE MATERIAL SOLUTIONS FOR NEXT GENERATION DATA CENTERS

At Fakuma 2026, Envalior showcases its latest material solutions for reliable data center power distribution, connectivity, and cooling components.Envalior materials and expertise help to...

Accord BioPharma Launches FILKRI™ (filgrastim-laha); Now Offers Both Long- and Short-Acting G-CSF Options

FILKRI is available with a permanent Q-code, standardizing the billing and reimbursement process across all sites of care.RALEIGH, N.C., Oct. 12, 2026 /PRNewswire/ -- Accord...

Foresee Pharmaceuticals Announces China NMPA Approval of CAMCEVI® 42 mg for the Treatment of Advanced Prostate Cancer; Changchun GeneScience Pharmaceutical will Commercialize in China

TAIPEI, Oct. 12, 2026 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced that it was notified by its licensing partner, Changchun GeneScience Pharmaceutical...

New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease

New Phase 3 AFFIRM data show higher rates of clinical and endoscopic response in Crohn's disease patients treated with subcutaneous SKYRIZI versus placebo across...

Celltrion to Present New Analyses of ZYMFENTRA® (infliximab-dyyb) in Crohn’s Disease and Ulcerative Colitis at ACG 2026

New data show favorable outcomes with subcutaneous infliximab following intravenous infliximab interruption, regardless of prior antibody status, in adult patients with moderate to severely...

Cardiotonic Agents Market to Reach USD 10,337.3 Million by 2034 – Credence Research

PUNE, India, Oct. 9, 2026 /PRNewswire/ -- The "Cardiotonic Agents Market – Growth, Share, Opportunities & Competitive Analysis, 2025–2034" report has been added to...

Cardiotonic Agents Market to Reach USD 10,337.3 Million by 2034 – Credence Research

PUNE, India, Oct. 9, 2026 /PRNewswire/ -- The "Cardiotonic Agents Market – Growth, Share, Opportunities & Competitive Analysis, 2025–2034" report has been added to...

Canara HSBC Life Insurance Reports Healthy H1 FY27 Results: Embedded Value Reaches ₹7,622 Crore, Operating RoEV at 19.8%; Traditional Products Drive VNB Growth

New Business Premium stood at ₹1,984 crore, registering year-on-year growth of 16.1%Individual weighted premium income (WPI) of ₹1,117 crore, with year-on-year growth of 14.5%Value...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsInjection